Список литературы

2658-6533

Research Results in Biomedicine

2658-6533

10.18413/2658-6533-2026-12-2-0-2

4152

Genetics

Investigation of SNP-SNP interactions of maternal organism in matrix metalloproteinases genes and folate cycle genes and their influence on birth weight

Reshetnikova

Yuliya N.

Reshetnikova

Yuliya N.

130226@bsuedu.ru

2026

12200

Background: The birth weight is one of the main parameters of the normal course of pregnancy. High/low birth weight is associated with the development of chronic diseases in adult life. The aim of the study: To study the SNP-SNP interactions of maternal organism in matrix metalloproteinases genes and folate cycle genes and the influence on birth weight. Materials and methods: Here we genotyped ten polymorphisms: five of matrix metalloproteinases genes (rs1799750 [1G>2G] MMP1, rs243865 [C>T] MMP2, rs3025058 [6A>5A] MMP3, rs11568818 [T>C] MMP7, rs17577 [G>A] MMP9) and five of folate cycle genes (rs1805087 [A>G] MTR, rs1801394 [G>A] MTRR, rs1979277 [C>T] SHMT1, rs699517 [C>T] TYMS, rs2790 [A>G] TYMS) in 691 pregnant women. SNP-SNP interactions were investigated using a modification of the multifactor dimensionality reduction analysis (MDR) – MB-MDR (Model Based Multifactor Dimensionality Reduction). The functional effects of weight-associated SNPs were assessed in silico. Results: According to the results of the study, 9 best models of intergenic interactions related to newborn weight were identified, which included all 10 studied SNPs (pperm ≤0.001). The maximum number of models was set for rs11568818 MMP7 (5 models) and rs1979277 SHMT1 (6 models). The 4-locus model rs1979277 SHMT1×rs11568818 MMP7×rs3025058 MMP3×rs1799750 MMP1 demonstrates the most significant association with birth weight. Conclusion: Thus, the SNP-SNP interactions of maternal organism in matrix metalloproteinases genes and folate cycle genes are associated with birth weight

birth weightpolymorphismmatrix metalloproteinase genesfolate cycle genesassociationsintergenic interactions

Список литературы

Martins JG, Biggio JR, Abuhamad A, et al. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). American Journal of Obstetrics and Gynecology. 2020;223(4):B2-B17. DOI: https://doi.org/10.1016/j.ajog.2020.05.010

Zur RL, Kingdom JC, Parks WT, et al. The Placental Basis of Fetal Growth Restriction. Obstetrics and gynecology clinics of North America. 2020;47(1):81-98. DOI: https://doi.org/10.1016/j.ogc.2019.10.008

Reshetnikov EA. Study of associations of candidate genes differentially expressing in the placenta with the development of placental insufficiency with fetal growth restriction. Research Results in Biomedicine. 2020;6(3):338-349. Russian. DOI: https://doi.org/10.18413/2658-6533-2020-6-3-0-5

Golovchenko OV. Molecular genetic determinants of pre-eclampsia. Research Results in Biomedicine. 2019;5(4):139-149. Russian. DOI: https://doi.org/10.18413/2658-6533-2019-5-4-0-11

Abramova MYu. Genetic markers of severe preeclampsia. Research Results in Biomedicine. 2022;8(3):305-316. Russian. DOI: https://doi.org/10.18413/2658-6533-2022-8-3-0-4

D'Agostin M, Di Sipio Morgia C, Vento G, et al. Long-term implications of fetal growth restriction. World Journal of Clinical Cases. 2023;11(3):2855-2863. DOI: https://doi.org/10.12998/wjcc.v11.i13.2855

Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. International Journal of Molecular Sciences. 2020;21(24):9739. DOI: https://doi.org/10.3390/ijms21249739

Chen J, Khalil RA. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Progress in Molecular Biology and Translational Science. 2017;148:87-165. DOI: https://doi.org/10.1016/bs.pmbts.2017.04.001

Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells. 2020;9(5):1076. DOI: https://doi.org/10.3390/cells9051076

Hiden U, Ghaffari-Tabrizi N, Gauster M, et al. Membrane-type matrix metalloproteinase 1 regulates trophoblast functions and is reduced in fetal growth restriction. American Journal of Pathology. 2013;182(5):1563-71. DOI: https://doi.org/10.1016/j.ajpath.2013.01.011

Zhu J, Zhong M, Pang ZJ, et al. Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction. Early Human Development. 2014;90(10):657-664. DOI: https://doi.org/10.1016/j.earlhumdev.2014.08.007

Su MT, Tsai PY, Tsai HL, et al. miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9. BioFactors. 2017;43(2):210-219. DOI: https://doi.org/10.1002/biof.1325

Garcha D, Walker SP, MacDonald TM, et al. Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria. Scientific Reports. 2021;11(1):16595. DOI: https://doi.org/10.1038/s41598-021-96077-1

Şahin B, Soyer-Çalışkan C, Çelik S, et al. Midregional pro-adrenomedullin and matrix metalloproteinase-2 levels in intrauterine growth restriction and small gestational age pregnancies: biochemical diagnostic difference. Journal of Maternal-Fetal and Neonatal Medicine. 2021;34(12):1999-2005. DOI: https://doi.org/10.1080/14767058.2020.1846707

Pei J, Li Y, Min Z, et al. MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction. Irish Journal of Medical Science. 2022;191(3):1251-1257. DOI: https://doi.org/10.1007/s11845-021-02664-6

Laskowska M, Dymara-Konopka W, Szmit E, et al. Matrix metalloproteinase-3 in preeclamptic and normotensive pregnancies complicated by foetal growth restriction. Heliyon. 2023;9(7):e18105. DOI: https://doi.org/10.1016/j.heliyon.2023.e18105

Jankovic-Karasoulos T, Furness DL, Leemaqz SY, et al. Maternal folate, one-carbon metabolism and pregnancy outcomes. Maternal and Child Nutrition. 2021;17(1):e13064. DOI: https://doi.org/10.1111/mcn.13064

Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metabolism. 2017;25(1):27-42. DOI: https://doi.org/10.1016/j.cmet.2016.08.009

Yeter A, Topcu HO, Guzel AI, et al. Maternal plasma homocysteine levels in intrauterine growth retardation. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(6):709-712. DOI: https://doi.org/10.3109/14767058.2014.929110

Jiang HL, Cao LQ, Chen HY. Blood folic acid, vitamin B12, and homocysteine levels in pregnant women with fetal growth restriction. Genetics and Molecular Research. 2016;15(4):gmr15048890. DOI: http://dx.doi.org/10.4238/gmr15048890

Liu C, Luo D, Wang Q, et al. Serum homocysteine and folate concentrations in early pregnancy and subsequent events of adverse pregnancy outcome: The Sichuan Homocysteine study. BMC Pregnancy and Childbirth. 2020;20:176. DOI: https://doi.org/10.1186/s12884-020-02860-9

Gaiday A, Balash L, Tussupkaliyev A. The role of high concentrations of homocysteine for the development of fetal growth restriction. Revista Brasileira de Ginecologia e Obstetricia. 2022;44(4):352-359. DOI: https://doi.org/10.1055/s-0042-1743093

Gremlich S, Nguyen D, Reymondin D, et al. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. Journal of Reproductive Immunology. 2007;74(1-2):143-151. DOI: https://doi.org/10.1016/j.jri.2007.02.001

Edwards DRV, Romero R, Kusanovic JP, et al. Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age. Journal of Maternal-Fetal and Neonatal Medicine. 2011;24(2):362-380. DOI: https://doi.org/10.3109/14767058.2010.497572

Sakowicz A, Lisowska M, Biesiada L, et al. Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia. Disease Markers. 2018;2018:1371425. DOI: https://doi.org/10.1155/2018/1371425

Gannoun MBA, Raguema N, Zitouni H, et al. MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study. Journal of Clinical Medicine. 2021;10(12):2647. DOI: https://doi.org/10.3390/jcm10122647

Jia JP, Wu JH, Hu JR. Correlations of MMP-9 and PPARγ gene polymorphisms with occurrence of preeclampsia. European Review for Medical and Pharmacological Sciences. 2022;26(3):771-778. DOI: https://doi.org/10.26355/eurrev_202202_27985

Yila TA, Sasaki S, Miyashita C, et al. Effects of maternal 5,10-methylenetetrahydrofolate reductase C677T and A1298C Polymorphisms and tobacco smoking on infant birth weight in a Japanese population. Journal of Epidemiology. 2012;22(2):91-102. DOI: https://doi.org/10.2188/jea.JE20110039

Sukla KK, Tiwari PK, Kumar A, et al. Low birthweight (LBW) and neonatal hyperbilirubinemia (NNH) in an Indian cohort: Association of homocysteine, its metabolic pathway genes and micronutrients as risk factors. PLoS ONE. 2013;8(9):e71587. DOI: https://doi.org/10.1371/journal.pone.0071587

Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. European Journal of Medical Genetics. 2015;58(1):1-10. DOI: https://doi.org/10.1016/j.ejmg.2014.10.004

Tiwari D, Bose PD, Das S, et al. MTHFR (C677T) polymorphism and PR (PROGINS) mutation as genetic factors for preterm delivery, fetal death and low birth weight: A Northeast Indian population based study. Meta Gene. 2015;3:31-42. DOI: https://doi.org/10.1016/j.mgene.2014.12.002

Kanehisa M, Furumichi M, Sato Y, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Research. 2023;51(D1):D587-D592. DOI: https://doi.org/10.1093/nar/gkac963

Rothfels K, Milacic M, Matthews L, et al. Using the Reactome Database. Current Protocols. 2023;3(4):e722. DOI: https://doi.org/10.1002/cpz1.722

Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Research. 2016;44(D1):D877-81. DOI: https://doi.org/10.1093/nar/gkv1340

Churnosov VI. Associations of polymorphic loci of candidate genes with the level of sex hormones in patients with endometrial hyperplasia. Research Results in Biomedicine. 2025;11(2):243-262. Russian. DOI: https://doi.org/10.18413/2658-6533-2025-11-2-0-3

Mahachie John JM, Cattaert T, Lishout FV, et al. Lower-order effects adjustment in quantitative traits model-based multifactor dimensionality reduction. PLoS ONE. 2012;7(1):e29594. DOI: https://doi.org/10.1371/journal.pone.0029594

Ponomareva TA. Genetic variants of sex hormone-binding globulin and hormonal profile in patients with genital endometriosis. Research Results in Biomedicine. 2025;11(1):75-90. Russian. DOI: https://doi.org/10.18413/2658-6533-2025-11-1-0-4

Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols. 2009;7:1073-1081. DOI: https://doi.org/10.1038/nprot.2009.86

Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics. 2013;7:7.20. DOI: https://doi.org/10.1002/0471142905.hg0720s76

GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318-1330. DOI: https://doi.org/10.1126/science.aaz1776

Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nature Genetics. 2013;45(10):1238-1243. DOI: https://doi.org/10.1038/ng.2756

Yang M, Liang C, Swaminathan K, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Science Advances. 2016;2(9):e1601167. DOI: https://doi.org/10.1126/sciadv.1601167

Gong JS, Kim GJ. The role of autophagy in the placenta as a regulator of cell death. Clinical and Experimental Reproductive Medicine. 2014;41(3):97-107. DOI: https://doi.org/10.5653/cerm.2014.41.3.97

Sellier C, Campanari ML, Corbier CJ, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. The EMBO Journal. 2016;35(12):1276-1297. DOI: https://doi.org/10.15252/embj.201593350

Nakashima A, Yamanaka-Tatematsu M, Fujita N, et al. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Autophagy. 2013;9(3):303-316. DOI: https://doi.org/10.4161/auto.22927

Gao L, Qi HB, Kamana KC, et al. Excessive autophagy induces the failure of trophoblast invasion and vasculature: possible relevance to the pathogenesis of preeclampsia. Journal of Hypertension. 2015;33(1):106-117. DOI: https://doi.org/10.1097/hjh.0000000000000366

Zhang S, Regnault TRH, Barker PL, et al. Placental adaptations in growth restriction. Nutrients. 2015;7(1):360-389. DOI: https://doi.org/10.3390/nu7010360

Dai Y, Li TH, He X, et al. The Effect and Mechanism of Asymmetric Dimethylarginine Regulating Trophoblastic Autophagy on Fetal Growth Restriction. Reproductive Sciences. 2021;28(7):2012-2022. DOI: https://doi.org/10.1007/s43032-020-00442-w

Jones P, Beckett E, Yates Z, et al. Converging evolutionary, environmental and clinical ideas on folate metabolism. Exploratory Research and Hypothesis in Medicine. 2016;1(3):34-41. DOI: https://doi.org/10.14218/ERHM.2016.00003b

Anderson DD, Stover PJ. SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. PLoS ONE. 2009;4(6):e5839. DOI: https://doi.org/10.1371/journal.pone.0005839

Li S, Wu Y, Gao Y, et al. Maternal hyperhomocysteinemia induces fetal growth restriction by suppressing angiogenesis at the maternal-fetal interface. Cell and Bioscience. 2026;16(1):17. DOI: https://doi.org/10.1186/s13578-025-01529-0

Engel SM, Olshan AF, Siega-Riz AM, et al. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. American Journal of Obstetrics and Gynecology. 2006;195(5):1231.e1-1231.e11. DOI: https://doi.org/10.1016/j.ajog.2006.07.024

Yang QQ, Zhang Y, Yang J. Association Between SHMT1 rs1979277 Polymorphism and Risk of Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis. Journal of Pediatric Hematology/Oncology. 2022;44(3):e616-e622. DOI: https://doi.org/10.1097/MPH.0000000000002173

Bahari G, Hashemi M, Naderi M, et al. Association of SHMT1 gene polymorphisms with the risk of childhood acute lymphoblastic leukemia in a sample of Iranian population. Cellular and Molecular Biology. 2016;62(2):45-51.

Li L, Ma Y, Jin C, et al. Polymorphism of cytosolic serine hydroxymethyltransferase and breast cancer risk: evidence from a meta-analysis. Tumor Biology. 2014;35(8):7361-7367. DOI: https://doi.org/10.1007/s13277-014-1964-3

Lim U, Peng K, Shane B, et al. Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. Journal of Nutrition. 2005;135(8):1989-1994. DOI: https://doi.org/10.1093/jn/135.8.1989

Wernimont SM, Raiszadeh F, Stover PJ, et al. Polymorphisms in serine hydroxymethyltransferase 1 and methylenetetrahydrofolate reductase interact to increase cardiovascular disease risk in humans. Journal of Nutrition. 2011;141(2):255-260. DOI: https://doi.org/10.3945/jn.110.132506